InsidersTradesSigma
Track the 삼천당제약 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 삼천당제약 has published 2 public disclosures. Market capitalisation: €3,698.4bn. The latest transaction was filed on 6 April 2026 (Mixed). Among the most active insiders: 전인석. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Samchundang Pharmaceutical is a South Korean pharmaceutical company focused on the development and manufacturing of medications. It is listed on the XKRX market.